Glenmark Pharmaceuticals standalone net profit rises 28.01% in the December 2020 quarter
Sales rise 12.60% to Rs 1949.82 crore
Net profit of Glenmark Pharmaceuticals rose 28.01% to Rs 442.33 crore in the quarter ended December 2020 as against Rs 345.53 crore during the previous quarter ended December 2019. Sales rose 12.60% to Rs 1949.82 crore in the quarter ended December 2020 as against Rs 1731.65 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales1949.821731.65 13 OPM %27.1923.88 -PBDT528.32448.46 18 PBT487.11410.64 19 NP442.33345.53 28Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content